Validity of the Patient-Reported Clinical Global Impression of Change as a Measure of Treatment Response in Men with Premature Ejaculation

被引:27
作者
Althof, Stanley E. [1 ]
Brock, Gerald B. [2 ]
Rosen, Raymond C. [3 ]
Rowland, David L. [4 ]
Aquilina, Joseph W. [5 ]
Rothman, Margaret [6 ]
Tesfaye, Fisseha [5 ]
Bull, Scott [5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Ctr Marital & Sexual Hlth S Florida, W Palm Beach, FL 33401 USA
[2] St Josephs Hlth Ctr, Dept Surg, Div Urol, London, ON, Canada
[3] New England Res Inst, Watertown, MA 02172 USA
[4] Valparaiso Univ, Valparaiso, IN 46383 USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[6] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
基金
美国国家卫生研究院;
关键词
Premature Ejaculation; Sexual Dysfunction; Clinical Global Impression of Change; Treatment; Dapoxetine; OUTCOME MEASURES; BEHAVIOR CHANGES; VALIDATION; QUESTIONNAIRE; SATISFACTION; DEFINITION; DEMENTIA; TRIALS; WOMEN; SCALE;
D O I
10.1111/j.1743-6109.2010.01793.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms and/or the relationship between CGIC and other validated PE patient-reported measures. Aim. The study aims to assess the validity of the patient-reported CGIC measure in men with PE and to examine the relationship between CGIC ratings and assessments of control, satisfaction, personal distress, and interpersonal difficulty. Methods. Data from a randomized, double-blind, 24-week phase 3 trial in 1,162 men with PE who received dapoxetine (30 mg or 60 mg) or placebo on demand provided the basis for the analysis. Patients were >= 18 years, in a stable monogamous relationship for >= 6 months, met the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision criteria for PE for >= 6 months, and had an intravaginal ejaculatory latency time (IELT) < 2 minutes in >= 75% of intercourse episodes. Main Outcome Measures. The CGIC asked patients to rate improvement or worsening of their PE compared with the start of the study using a 7-point response scale; other patient-reported measures were control over ejaculation, satisfaction with sexual intercourse, interpersonal difficulty, and personal distress related to ejaculation. Stopwatch-measured IELT was recorded. Associations between CGIC and change in other measures at study end point were assessed. Results. The magnitude of IELT increased for each category of improvement on the CGIC: 1.63, 4.03, and 7.15 minutes for slightly better, better, and much better, respectively. Higher CGIC ratings were correlated with greater improvement in control (r = 0.73), satisfaction (r = 0.62), greater reduction in distress (r = -0.52), and interpersonal difficulty (r = -0.39). Total variance accounted for was 57.4%: control (48.7%), satisfaction (4.5%), IELT (2.8%), and distress (1.15%). Conclusions. The analyses support the validity of the CGIC measure in men with PE. The CGIC can provide clinicians in practice with a valid and brief outcome assessment of their patient's condition. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, and Bull S. Validity of the patient-reported clinical global impression of change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-2252.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 50 条
  • [21] The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services
    McAllister, M.
    Wood, A. M.
    Dunn, G.
    Shiloh, S.
    Todd, C.
    CLINICAL GENETICS, 2011, 79 (05) : 413 - 424
  • [22] Developing CollaboRATE: A fast and frugal patient-reported measure of shared decision making in clinical encounters
    Elwyn, Glyn
    Barr, Paul James
    Grande, Stuart W.
    Thompson, Rachel
    Walsh, Thom
    Ozanne, Elissa M.
    PATIENT EDUCATION AND COUNSELING, 2013, 93 (01) : 102 - 107
  • [23] Response to validity of patient-reported outcome measures in atopic eczema/dermatitis REPLY
    Soyiri, Ireneous N.
    Nwaru, Bright I.
    Sheikh, Aziz
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2017, 28 (07) : 700 - 700
  • [24] Prevalence and impact of premature ejaculation in outpatients complaining of ejaculating prematurely: using the instruments of intravaginal ejaculatory latency time and patient-reported outcome measures
    J Gao
    X Zhang
    P Su
    K Shi
    D Tang
    Z Hao
    J Zhou
    C Liang
    International Journal of Impotence Research, 2014, 26 : 94 - 99
  • [25] Prevalence and impact of premature ejaculation in outpatients complaining of ejaculating prematurely: using the instruments of intravaginal ejaculatory latency time and patient-reported outcome measures
    Gao, J.
    Zhang, X.
    Su, P.
    Shi, K.
    Tang, D.
    Hao, Z.
    Zhou, J.
    Liang, C.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2014, 26 (03) : 94 - 99
  • [26] Development of a patient-reported outcome measure in limb reconstruction A PILOT STUDY ASSESSING FACE VALIDITY
    Wright, J.
    Timms, A.
    Fugazzotto, S.
    Goodier, D.
    Calder, P.
    BONE & JOINT OPEN, 2021, 2 (09): : 705 - 709
  • [27] Clinical Value of a Patient-Reported Goal-Attainment Measure: The Global Development of Self-Assessment Goal Achievement (SAGA) Questionnaire for Patients With Lower Urinary Tract Symptoms
    Khullar, Vik
    Espuna-Pons, Monserrat
    Marschall-Kehrel, Daniela
    Fianu-Jonasson, Aino
    Kelleher, Con J.
    Brubaker, Linda
    Beach, James
    Piault, Elisabeth
    Trocio, Jeffrey
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 90 - 94
  • [28] Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis
    Bogan R.K.
    Black J.
    Swick T.
    Mamelak M.
    Kovacevic-Ristanovic R.
    Villa K.F.
    Mori F.
    Montplaisir J.
    Neurology and Therapy, 2017, 6 (2) : 237 - 245
  • [29] Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
    Boye, Kristina S.
    Stewart, Katie D.
    Matza, Louis S.
    DIABETES THERAPY, 2023, 14 (09) : 1451 - 1470
  • [30] Content Validity for the VVSymQ® Instrument: A New Patient-Reported Outcome Measure for the Assessment of Varicose Veins Symptoms
    Paty, Jean
    Elash, Celeste A.
    Turner-Bowker, Diane M.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2017, 10 (01) : 51 - 63